BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34969760)

  • 1. Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells.
    Kushiyama S; Yashiro M; Yamamoto Y; Sera T; Sugimoto A; Nishimura S; Togano S; Kuroda K; Okuno T; Miki Y; Ohira M
    Anticancer Res; 2022 Jan; 42(1):501-509. PubMed ID: 34969760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
    Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells.
    Fuyuhiro Y; Yashiro M; Noda S; Kashiwagi S; Matsuoka J; Doi Y; Kato Y; Hasegawa T; Sawada T; Hirakawa K
    Br J Cancer; 2011 Sep; 105(7):996-1001. PubMed ID: 21863023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.
    Yashiro M; Matsuoka T; Ohira M
    Hum Cell; 2018 Oct; 31(4):271-281. PubMed ID: 29876827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
    Nakazawa K; Yashiro M; Hirakawa K
    Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
    Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
    Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.
    Satoyoshi R; Kuriyama S; Aiba N; Yashiro M; Tanaka M
    Oncogene; 2015 Jan; 34(5):650-60. PubMed ID: 24441039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidates for driver oncogenes in scirrhous-type gastric cancer cell lines.
    Sai E; Miwa Y; Takeyama R; Kojima S; Ueno T; Yashiro M; Seto Y; Mano H
    Cancer Sci; 2019 Aug; 110(8):2643-2651. PubMed ID: 31222839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a new scirrhous gastric carcinoma cell line with microsatellite instability.
    Koyama T; Yashiro M; Matsuoka T; Sunami T; Ohira M; Hirakawa K
    Oncol Rep; 2004 Aug; 12(2):317-21. PubMed ID: 15254696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
    Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
    Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
    Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
    Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis.
    Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
    Br J Cancer; 1995 Nov; 72(5):1200-10. PubMed ID: 7577468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
    Yashiro M; Chung YS; Sowa M
    Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.
    Inoue T; Chung YS; Yashiro M; Nishimura S; Hasuma T; Otani S; Sowa M
    Jpn J Cancer Res; 1997 Feb; 88(2):152-9. PubMed ID: 9119743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts.
    Yashiro M; Chung YS; Kubo T; Hato F; Sowa M
    Br J Cancer; 1996 Oct; 74(7):1096-103. PubMed ID: 8855981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments.
    Kinoshita H; Yashiro M; Fukuoka T; Hasegawa T; Morisaki T; Kasashima H; Masuda G; Noda S; Hirakawa K
    Carcinogenesis; 2015 Dec; 36(12):1511-20. PubMed ID: 26385890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14.
    Okuno T; Yashiro M; Masuda G; Togano S; Kuroda K; Miki Y; Hirakawa K; Ohsawa M; Wanibuchi H; Ohira M
    Ann Surg Oncol; 2019 Apr; 26(4):1093-1102. PubMed ID: 30652228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
    Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
    Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
    Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
    Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus.
    Murahashi K; Yashiro M; Takenaka C; Matsuoka T; Ohira M; Chung KH
    Int J Oncol; 2001 Nov; 19(5):1029-33. PubMed ID: 11605005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.